187 related articles for article (PubMed ID: 12887693)
1. Functional coupling of serotonin and noradrenaline transporters.
Horschitz S; Hummerich R; Schloss P
J Neurochem; 2003 Aug; 86(4):958-65. PubMed ID: 12887693
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.
Kocabas AM; Rudnick G; Kilic F
J Neurochem; 2003 Jun; 85(6):1513-20. PubMed ID: 12787070
[TBL] [Abstract][Full Text] [Related]
3. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
Owens MJ; Knight DL; Nemeroff CB
Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
5. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
6. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
Owens JM; Knight DL; Nemeroff CB
Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
[TBL] [Abstract][Full Text] [Related]
7. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
Blakely RD; Moore KR; Qian Y
Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
[No Abstract] [Full Text] [Related]
8. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
Barker EL; Blakely RD
Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
[No Abstract] [Full Text] [Related]
9. Pharmacological profile of neuroleptics at human monoamine transporters.
Tatsumi M; Jansen K; Blakely RD; Richelson E
Eur J Pharmacol; 1999 Mar; 368(2-3):277-83. PubMed ID: 10193665
[TBL] [Abstract][Full Text] [Related]
10. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Béïque JC; Lavoie N; de Montigny C; Debonnel G
Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
[TBL] [Abstract][Full Text] [Related]
11. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
12. Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs.
Moore KR; Blakely RD
Biotechniques; 1994 Jul; 17(1):130-5, 137. PubMed ID: 7946295
[TBL] [Abstract][Full Text] [Related]
13. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus-mediated expression of neurotransmitter transporters.
Tate CG
Methods Enzymol; 1998; 296():443-55. PubMed ID: 9779466
[No Abstract] [Full Text] [Related]
15. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
Skolnick P; Popik P; Janowsky A; Beer B; Lippa AS
Eur J Pharmacol; 2003 Feb; 461(2-3):99-104. PubMed ID: 12586204
[TBL] [Abstract][Full Text] [Related]
16. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
[TBL] [Abstract][Full Text] [Related]
17. DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer.
Hummerich R; Reischl G; Ehrlichmann W; Machulla HJ; Heinz A; Schloss P
J Neurochem; 2004 Sep; 90(5):1218-26. PubMed ID: 15312176
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
19. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.
Hébert C; Habimana A; Elie R; Reader TA
Neurochem Int; 2001 Jan; 38(1):63-74. PubMed ID: 10913689
[TBL] [Abstract][Full Text] [Related]
20. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
Bryan-Lluka LJ; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
